Features
256 - 270 of 665 results
Gil Y. Roth
July 9, 2010
Catching up with PGM Senior VP Tony Maddaluna after Pfizer's restructuring plans were revealed
Read More »
Gil Roth
July 9, 2010
Our rules for inclusion on the Top 10 Biopharma list are as follows: you’re a biopharma company if more than half of your drug revenues — not royalties — come from large-molecule drugs and vaccines. It’s arbitrary, but it&rs…
Read More »
Gil Roth
July 9, 2010
Slowing sales, mega-mergers, generic implosions and whipsawing exchange rates have caused some shakeups within the Top 20 Pharma ranks. The loss of Wyeth and Schering-Plough, coupled with Roche’s defection to the Biopharma list, led us to find…
Read More »
Gil Y. Roth
June 1, 2010
window.location="http://www.contractpharma.com/contents/view_salary-survey/2010-06-15/2010---eleventh-annual-salary-survey/"…
Read More »
Dr. Ferzaan Engineer and Dr. Anand Tharmaratnam
June 1, 2010
The region’s strategic shift from outsourcing to innovation
Read More »
Gil Y. Roth
May 11, 2010
Welcome to our 6th Annual Contract Pharma Outsourcing Survey! More than 350 sponsor-side respondents offered up their opinions on outsourcing trends for this year’s poll. Here’s a breakdown of the respondents, by company type & job function:
Read More »
256 - 270 of 665 results
